Cambridgeshire, United Kingdom

Stephanie Maine

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie Maine. Retrieved from https://idiyas.com/inventor/stephanie-maine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Cambridge, GB (2015)
  • Cambridgeshire, GB (2018 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephanie Maine

Introduction

Stephanie Maine is a prominent inventor based in Cambridgeshire, GB. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of orexin receptor antagonists. With a total of three patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Among her latest patents, Stephanie has developed compounds of formula (I) that serve as orexin receptor antagonists. These compounds, along with their pharmaceutically acceptable salts, are detailed in her patent specifications. The inventions provide processes for their preparation, pharmaceutical compositions containing them, and their therapeutic uses. This innovative work highlights her commitment to advancing medical science.

Career Highlights

Stephanie Maine is currently associated with Takeda Pharmaceutical Company Limited, where she continues to push the boundaries of pharmaceutical research. Her role at Takeda allows her to collaborate with other experts in the field and contribute to groundbreaking research initiatives.

Collaborations

Some of her notable coworkers include Charlotte Fieldhouse and Angela Glen. Their collaborative efforts enhance the research environment and foster innovation within the company.

Conclusion

Stephanie Maine's contributions to the field of pharmaceuticals through her innovative patents and collaborative work exemplify her dedication to advancing medical science. Her ongoing research promises to lead to significant advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…